AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26381921 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit Training (CT)
Number of subjects: 40
Study 26381921 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxing Training (RT)
Number of subjects: 40
Study 24267363 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral desensitization (200 mL of cow's milk daily)
Number of subjects: 31
Study 24267363 — intervention group
Group type: COMPARATOR
Intervention: Elimination diet
Number of subjects: 31
Study 22122955 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) administered perorally after shooting
Number of subjects: 34
Study 22122955 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NAC)
Number of subjects: 34
Study 18366658 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 0
Study 18366658 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16981641 — intervention group
Group type: EXPERIMENTAL
Intervention: Contextual information provided in social norms marketing approach
Number of subjects: 0
Study 16981641 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 12716664 — intervention group
Group type: EXPERIMENTAL
Intervention: Stearidonic acid (SDA)
Number of subjects: 30
Study 12716664 — intervention group
Group type: COMPARATOR
Intervention: Alpha-linolenic acid (ALA)
Number of subjects: 30
Study 12716664 — intervention group
Group type: COMPARATOR
Intervention: Eicosapentaenoic acid (EPA)
Number of subjects: 30
Study 12743836 — intervention group
Group type: EXPERIMENTAL
Intervention: Cast gold partial crowns (CGPC)
Number of subjects: 64
Study 12743836 — intervention group
Group type: COMPARATOR
Intervention: Ceramic partial crowns (CPC)
Number of subjects: 64
Study 9790159 — intervention group
Group type: COMPARATOR
Intervention: Nimodipine monotherapy
Number of subjects: 30
Study 9790159 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine with carbamazepine augmentation
Number of subjects: 30
Study 9790159 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine-carbamazepine combination
Number of subjects: 30
Study 9790159 — intervention group
Group type: COMPARATOR
Intervention: Verapamil substitution for nimodipine
Number of subjects: 30
Study 9790159 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine transition to isradipine
Number of subjects: 30
Study 8580801 — intervention group
Group type: EXPERIMENTAL
Intervention: ProMECE‐CytaBOM (P‐C)
Number of subjects: 210
Study 8580801 — intervention group
Group type: COMPARATOR
Intervention: MACOP‐B (M‐B)
Number of subjects: 210
Study 2561036 — intervention group
Group type: EXPERIMENTAL
Intervention: metoprolol (200 mg/die)
Number of subjects: 121
Study 2561036 — intervention group
Group type: COMPARATOR
Intervention: gallopamil
Number of subjects: 121
Study 2561036 — intervention group
Group type: EXPERIMENTAL
Intervention: combined therapy with atenolol (50 mg) and nifedipine (20 mg)
Number of subjects: 121
Study 2561036 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg acebutolol and 20 mg nifedipine
Number of subjects: 121
Study 2561036 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg atenolol and 10 mg enalapril
Number of subjects: 121
Study 2561036 — intervention group
Group type: EXPERIMENTAL
Intervention: all treatments
Number of subjects: 121
Study 807222 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen
Number of subjects: 64
Study 28103950 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral ventilation tube insertion
Number of subjects: 230
Study 28103950 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (no tube)
Number of subjects: 230
Study 25820119 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer Aided Surgery (CAS) performed by trainee surgeons
Number of subjects: 92
Study 25820119 — intervention group
Group type: COMPARATOR
Intervention: Computer Aided Surgery (CAS) performed by consultant orthopedic surgeons
Number of subjects: 92
Study 23722573 — intervention group
Group type: EXPERIMENTAL
Intervention: Squat posture with mental processing using arithmetic tasks
Number of subjects: 13
Study 23722573 — intervention group
Group type: EXPERIMENTAL
Intervention: Stoop posture with mental processing using arithmetic tasks
Number of subjects: 13
Study 23722573 — intervention group
Group type: COMPARATOR
Intervention: Squat posture without mental processing
Number of subjects: 13
Study 23722573 — intervention group
Group type: COMPARATOR
Intervention: Stoop posture without mental processing
Number of subjects: 13
Study 21855244 — intervention group
Group type: EXPERIMENTAL
Intervention: Boswellia serrata gum resin extracts (BSE) at a high dose of 4200 mg per day
Number of subjects: 27
Study 21855244 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 19570388 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 40
Study 19570388 — intervention group
Group type: COMPARATOR
Intervention: Carotid stenting (CAS)
Number of subjects: 40
Study 19570388 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of hospitalization for CEA
Number of subjects: 40
Study 19570388 — intervention group
Group type: COMPARATOR
Intervention: Cost of hospitalization for CAS
Number of subjects: 40
Study 17274236 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal mouthwash containing the pericarp extract of Garcinia mangostana L
Number of subjects: 60
Study 17274236 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 60
Study 15569120 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 829
Study 15569120 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 829
Study 11571769 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher behavioral disturbance group (n = 148)
Number of subjects: 383
Study 11571769 — intervention group
Group type: COMPARATOR
Intervention: Lower behavioral disturbance group (n = 235)
Number of subjects: 383
Study 9778079 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus (DM) alone
Number of subjects: 2531
Study 9778079 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension (HTN) alone
Number of subjects: 2531
Study 9778079 — intervention group
Group type: EXPERIMENTAL
Intervention: Both DM and HTN
Number of subjects: 2531
Study 9778079 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking with DM and HTN
Number of subjects: 2531
Study 7866636 — intervention group
Group type: EXPERIMENTAL
Intervention: Triplex PCR
Number of subjects: 47
Study 7866636 — intervention group
Group type: COMPARATOR
Intervention: Culture methods
Number of subjects: 47
Study 7866636 — intervention group
Group type: COMPARATOR
Intervention: Microscopy
Number of subjects: 47
Study 3154688 — intervention group
Group type: EXPERIMENTAL
Intervention: molsidomine
Number of subjects: 270
Study 3154688 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 270
Study 31330515 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive frailty
Number of subjects: 495
Study 31439409 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective connectivity from left anterior cingulate cortex (ACC) to right hippocampus
Number of subjects: 27
Study 31439409 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-word Stroop task
Number of subjects: 27
Study 28900247 — intervention group
Group type: EXPERIMENTAL
Intervention: pRJ 1.2 g/d
Number of subjects: 194
Study 28900247 — intervention group
Group type: EXPERIMENTAL
Intervention: pRJ 4.8 g/d
Number of subjects: 194
Study 28900247 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study 28900247 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical performance tests (six-minute walk test, timed up and go test, standing on one leg with eyes closed)
Number of subjects: 194
Study 26482492 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral interleaved deep brain stimulation in the subthalamic nucleus/substantia nigra pars reticulata region
Number of subjects: 0
Study 23359265 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine 200 mg once-daily regimen
Number of subjects: 532
Study 20683766 — intervention group
Group type: EXPERIMENTAL
Intervention: omega-3 fatty acids (1.3 g/day)
Number of subjects: 27
Study 20683766 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 27
Study 19666638 — intervention group
Group type: EXPERIMENTAL
Intervention: Right ventricular pacing (VPinSR)
Number of subjects: 554
Study 19666638 — intervention group
Group type: COMPARATOR
Intervention: Synchronous pacing modalities (ASVP, APVP, APVS)
Number of subjects: 554
Study 16960025 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR) - 20% calorically-restricted diet (n = 19)
Number of subjects: 48
Study 16960025 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (EX) - designed to produce a similar energy deficit (n = 19)
Number of subjects: 48
Study 16960025 — intervention group
Group type: COMPARATOR
Intervention: Healthy lifestyle control (HL) - control group (n = 10)
Number of subjects: 48
Study 15376310 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 79
Study 15376310 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 79
Study 11694665 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP SB
Number of subjects: 4217
Study 11694665 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP CB
Number of subjects: 4217
Study 11694665 — intervention group
Group type: COMPARATOR
Intervention: DT
Number of subjects: 4217
Study 9493479 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba/ginseng combination 320 mg b.i.d.
Number of subjects: 64
Study 9493479 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba/ginseng combination 80 mg b.i.d.
Number of subjects: 64
Study 9493479 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 7971111 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditions designed to promote integration of shape and texture
Number of subjects: 0
Study 7971111 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditions designed to impede integration of shape and texture
Number of subjects: 0
Study 2822294 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (10 mg as a bolus)
Number of subjects: 10
Study 2822294 — intervention group
Group type: COMPARATOR
Intervention: Naloxone after dexamethasone (2 mg)
Number of subjects: 10
Study 31451566 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training (CT) intervention for 16 weeks
Number of subjects: 0
Study 31451566 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 0
Study 31451566 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training (CT) intervention
Number of subjects: 0
Study 28858418 — intervention group
Group type: EXPERIMENTAL
Intervention: Contracted endodontic cavity (CEC) access with 35% carbamide peroxide
Number of subjects: 42
Study 28858418 — intervention group
Group type: COMPARATOR
Intervention: Traditional endodontic cavity (TEC) access with 35% carbamide peroxide
Number of subjects: 42
Study 28858418 — intervention group
Group type: COMPARATOR
Intervention: Comparison of CEC and TEC designs
Number of subjects: 42
Study 27849643 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac (100 mg)
Number of subjects: 372
Study 27849643 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (100 mg)
Number of subjects: 372
Study 27849643 — intervention group
Group type: COMPARATOR
Intervention: Naproxen (500 mg)
Number of subjects: 372
Study 27849643 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac and Indomethacin
Number of subjects: 372
Study 27849643 — intervention group
Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 372
Study 26615516 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol (500 mcg/kg bolus 10 min before induction, followed by 200 mcg/kg/min infusion)
Number of subjects: 42
Study 26615516 — intervention group
Group type: COMPARATOR
Intervention: Control group (no esmolol)
Number of subjects: 42
Study 22954393 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose tirofiban (10 μg/kg bolus, 0.15 μg/kg/min infusion for 48 h)
Number of subjects: 163
Study 22954393 — intervention group
Group type: COMPARATOR
Intervention: Half-dose tirofiban (5 μg/kg bolus, 0.075 μg/kg/min infusion for 48 h)
Number of subjects: 163
Study 22954393 — intervention group
Group type: COMPARATOR
Intervention: Half-dose tirofiban
Number of subjects: 163
Study 22954393 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Standard-dose and Half-dose tirofiban)
Number of subjects: 163
Study 20803038 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal jugular access
Number of subjects: 403
Study 20803038 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclavian access
Number of subjects: 403
Study 20803038 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalic vein access
Number of subjects: 403
Study 20803038 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative therapies
Number of subjects: 403
Study 20803038 — intervention group
Group type: COMPARATOR
Intervention: Depression and anxiety scores (HADS)
Number of subjects: 403
Study 17845540 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN 3 MU daily plus ribavirin (RBV) 1000 mg/day for 4 weeks, followed by IFN 3 MU TIW plus RBV 1000 mg/day for 44 weeks (induction)
Number of subjects: 876
Study 17845540 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN 5 MU B.I.D. plus RBV 1000-1200 mg/day for 2 weeks, followed by pegylated IFN (PEG-IFN) 75-150 mug weekly plus RBV 1000-1200 mg/day for 46 weeks (induction)
Number of subjects: 876
Study 17845540 — intervention group
Group type: COMPARATOR
Intervention: IFN 3 MU TIW plus RBV 1000 mg/day for 48 weeks (non-induction)
Number of subjects: 876
Study 17845540 — intervention group
Group type: COMPARATOR
Intervention: PEG-IFN 75-150 mug weekly plus RBV 1000-1200 mg/day for 48 weeks (non-induction)
Number of subjects: 876
Study 15168037 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise followed by a CHO-rich diet (> 10 g/kg body mass/24 h)
Number of subjects: 20
Study 15168037 — intervention group
Group type: COMPARATOR
Intervention: Resting (no exercise)
Number of subjects: 20
Study 11594097 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic GBP
Number of subjects: 101
Study 11594097 — intervention group
Group type: EXPERIMENTAL
Intervention: Open GBP
Number of subjects: 101
Study 9853438 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical recombinant bovine basic fibroblast growth factor (rbFGF) 150 AU/cm2 daily
Number of subjects: 600
Study 9853438 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus vehicle
Number of subjects: 600
Study 7985636 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B-12 alone
Number of subjects: 184
Study 7985636 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B-12 combined with folate
Number of subjects: 184
Study 7985636 — intervention group
Group type: COMPARATOR
Intervention: Folate alone
Number of subjects: 184
Study 7985636 — intervention group
Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 184
Study 2577555 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant portal therapy of the liver with resection of the colorectal primary malignancy
Number of subjects: 657
Study 2577555 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant treatment of the liver following curative resection of colorectal liver metastases
Number of subjects: 657
Study 2577555 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative local chemotherapy (FUDR, pump) for unresectable colorectal liver metastases
Number of subjects: 657
Study 2577555 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoembolisation (Frankfurt method) for primary non-resectable liver malignancies
Number of subjects: 657
Study 31597476 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level transcutaneous electrical stimulation (LLTS) of the greater auricular nerve, amplitude 1 mA, frequency 1 Hz for 40 minutes, followed by a 20 minutes break, for up to 2 weeks after cardiac surgery
Number of subjects: 40
Study 31597476 — intervention group
Group type: COMPARATOR
Intervention: Control group (sham stimulation)
Number of subjects: 40
Study 31597476 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level transcutaneous electrical stimulation (LLTS) of the greater auricular nerve
Number of subjects: 40
Study 29723874 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (anticoagulant interrupted)
Number of subjects: 7193
Study 29723874 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-dose edoxaban regimen (HDER) (anticoagulant interrupted)
Number of subjects: 7193
Study 29723874 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-dose edoxaban regimen (LDER) (anticoagulant interrupted)
Number of subjects: 7193
Study 29723874 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (anticoagulant continued)
Number of subjects: 7193
Study 29723874 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-dose edoxaban regimen (HDER) (anticoagulant continued)
Number of subjects: 7193
Study 29723874 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-dose edoxaban regimen (LDER) (anticoagulant continued)
Number of subjects: 7193
Study 26250501 — intervention group
Group type: EXPERIMENTAL
Intervention: Muffins enriched with 20% sour cherry pomace (CP)
Number of subjects: 0
Study 26250501 — intervention group
Group type: EXPERIMENTAL
Intervention: Muffins enriched with 30% sour cherry pomace (CP)
Number of subjects: 0
Study 26250501 — intervention group
Group type: EXPERIMENTAL
Intervention: Muffins enriched with sour cherry pomace (CP)
Number of subjects: 0
Study 25362669 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable ECG‐LWs
Number of subjects: 7238
Study 25362669 — intervention group
Group type: COMPARATOR
Intervention: Reusable ECG‐LWs
Number of subjects: 7238
Study 22525595 — intervention group
Group type: COMPARATOR
Intervention: Retrospective ECG‐gated protocol (group 1)
Number of subjects: 96
Study 22525595 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective ECG‐triggering protocol with acquisition window of 380 ms (group 2)
Number of subjects: 96
Study 22525595 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective ECG‐triggering protocol with acquisition window of 200 ms (group 3)
Number of subjects: 96
Study 19230717 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood glucose (SMBG)
Number of subjects: 1102
Study 17850734 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin plus pioglitazone
Number of subjects: 32
Study 17850734 — intervention group
Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 32
Study 15780111 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular ultrasound examinations every 3 months in addition to traditional screening methods.
Number of subjects: 192
Study 15780111 — intervention group
Group type: COMPARATOR
Intervention: Traditional screening methods only (without ultrasound).
Number of subjects: 192
Study 14628158 — intervention group
Group type: EXPERIMENTAL
Intervention: Removal of hypertrophied anal papillae and fibrous anal polyps by radiofrequency surgery
Number of subjects: 140
Study 14628158 — intervention group
Group type: COMPARATOR
Intervention: Control group (no removal of polyps and papillae)
Number of subjects: 140
Study 10918084 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (Cr) 5 g + 5 g maltodextrin
Number of subjects: 14
Study 10918084 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P) 5 g maltodextrin
Number of subjects: 14
Study 10918084 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine (Cr)
Number of subjects: 14
Study 10918084 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 14
Study 8893110 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg once daily
Number of subjects: 188
Study 8893110 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyzine 25 mg tid
Number of subjects: 188
Study 8893110 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study 1994554 — intervention group
Group type: EXPERIMENTAL
Intervention: Takeda TM 2420 automatic ambulant device for measuring blood pressure
Number of subjects: 69
Study 1994554 — intervention group
Group type: COMPARATOR
Intervention: Hawksley random zero manometer
Number of subjects: 69
Study 1994554 — intervention group
Group type: EXPERIMENTAL
Intervention: Takeda TM 2420 24-hour monitoring
Number of subjects: 69
Study 6141704 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation therapy (R)
Number of subjects: 103
Study 6141704 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal therapy (B)
Number of subjects: 103
Study 6141704 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist‐directed prolonged exposure in vivo (PE)
Number of subjects: 103
Study 6141704 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamically oriented supportive therapy (ST)
Number of subjects: 103
Study 31059148 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscope and micro-camera assessment with 3 mm membrane elevation height (MEH)
Number of subjects: 5
Study 31059148 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscope and micro-camera assessment with 6 mm membrane elevation height (MEH)
Number of subjects: 5
Study 31059148 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscope and micro-camera assessment
Number of subjects: 5
Study 28625832 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 104
Study 28625832 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 104
Study 28625832 — intervention group
Group type: COMPARATOR
Intervention: Sham diet
Number of subjects: 104
Study 26928962 — intervention group
Group type: EXPERIMENTAL
Intervention: ENGERIX-B
Number of subjects: 72
Study 26928962 — intervention group
Group type: COMPARATOR
Intervention: Sci-B-Vac
Number of subjects: 72
Study 24439238 — intervention group
Group type: EXPERIMENTAL
Intervention: Day patient treatment (DP) after 3 weeks of inpatient care
Number of subjects: 172
Study 24439238 — intervention group
Group type: COMPARATOR
Intervention: Inpatient treatment (IP)
Number of subjects: 172
Study 24439238 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IP and DP)
Number of subjects: 172
Study 22823994 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard of care treatment + SABR to all sites of known disease
Number of subjects: 99
Study 22823994 — intervention group
Group type: COMPARATOR
Intervention: Current standard of care treatment
Number of subjects: 99
Study 18562265 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound drains
Number of subjects: 107